|Articles|December 4, 2020
HIC Analysis of Drug-to-Antibody Ratio
Author(s)Agilent Technologies, Inc.
This application note demonstrates the DAR determination of brentuximab vedotin using HIC. Excellent reproducibility was found with the Agilent 1290 Infinity II Bio LC.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Best of the Week: Profiling Endoenous Protein Complexes, Previewing Riva 2026
2
Riva Returns Alive and Kicking
3
Exercise-Induced Gut-Brain Axis Modulation in Autism: Insights from Chromatographic Metabolite Analysis
4
Restek Introduces GC Columns Featuring TriMax Technology for Trace-level Sensitivity
5